STOCK TITAN
  1. Home
  2. News
  3. OPCH

Option Care Health Inc. - OPCH STOCK NEWS

Welcome to our dedicated news page for Option Care Health (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Option Care Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Option Care Health's position in the market.

News
Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024
Rhea-AI Summary
Option Care Health, Inc. (Nasdaq: OPCH) announces strong financial results for the first quarter ended March 31, 2024, with net revenue of $1,146.1 million, up 12.8% from the previous year. The company reported a gross profit of $238.5 million, net income of $44.8 million, and adjusted EBITDA of $98.3 million. Despite a decrease in cash flow from operations due to a cybersecurity incident, Option Care Health remains financially robust with a cash balance of $219.5 million. The company also completed stock repurchases of $40.0 million and received the 2024 Gallup Exceptional Workplace Award. Updated full-year 2024 financial guidance includes expected net revenue of $4.65 billion to $4.8 billion, adjusted EBITDA of $430 million to $450 million, and cash flow from operations of at least $300 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
earnings
-
News
Option Care Health to Announce First Quarter 2024 Financial Results and Host Conference Call
Rhea-AI Summary
Option Care Health Inc. announces the release of its first-quarter results for 2024 on April 23, 2024. The management team will host a conference call to review the results at 8:30 a.m. E.T. Participants can pre-register for the call and access a live audio webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.11%
Tags
earnings
-
News
Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023
Rhea-AI Summary
Option Care Health, Inc. (OPCH) reported strong financial results for Q4 and full year 2023, with net revenue reaching $1,124.4 million and $4,302.3 million, respectively. The company saw increases in gross profit, net income, adjusted EBITDA, and cash flow from operations. Share repurchases totaling $250 million were fulfilled, with an additional $250 million authorized. CEO John C. Rademacher highlighted the focus on clinical excellence and patient care. The company provided financial guidance for 2024, expecting net revenue of $4.6 billion to $4.8 billion, adjusted EBITDA of $425 million to $450 million, and cash flow from operations of at least $300 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.43%
Tags
earnings
News
Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call
Rhea-AI Summary
Option Care Health Inc. will release its fourth quarter and full year results on February 22, 2024. The management team will host a conference call to review the results. Participants can pre-register for the call and access it via live audio webcast. A replay will be available for on-demand listening.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
earnings
-
News
Option Care Health Selects Palantir’s Artificial Intelligence Platform for Enterprise-Wide Digital Transformation
Rhea-AI Summary
Palantir Technologies Inc. (PLTR) and Option Care Health Inc. (OPCH) announced a multi-year commercial partnership to leverage Palantir's AI software to improve patient outcomes and increase efficiency. Option Care Health will use Palantir's Artificial Intelligence Platform (AIP) across nurse scheduling, patient onboarding, purchasing optimization, and supply chain execution. The partnership aims to optimize visits per day, increase patient face time with clinicians, reduce administrative burden, and ensure stockage of drugs and medical supplies while preventing overstocking. Palantir's software is also used across government health organizations, including the National Institutes of Health and the U.K.'s National Health Service.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.9%
Tags
none
-
News
Option Care Health to Participate in the J.P. Morgan Healthcare Conference
Rhea-AI Summary
Option Care Health Inc. (OPCH) to participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024, with a presentation at 3:00pm PT. The webcast and presentation materials will be available online at the company's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.28%
Tags
conferences
News
Option Care Health Announces Increased Share Repurchase Authorization
Rhea-AI Summary
Option Care Health, Inc. (OPCH) announced plans to complete the remaining $75 million of repurchases in Q4 and an increase in share repurchase program authorization from $250 million to $500 million, with no specified expiration date.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
buyback
-
News
Option Care Health To Participate In Upcoming Investor Conferences
Rhea-AI Summary
Option Care Health Inc. (OPCH) to Participate in Investor Conferences, Including Jefferies London Healthcare Conference and Bank of America Events, Webcast Links Available Online
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
conferences
-
News
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2023
Rhea-AI Summary
Option Care Health, Inc. reports financial results for Q3 2023, with net revenue of $1.09 billion, up 7.1% compared to the previous year. Gross profit increases by 16.6% to $254.3 million. Net income rises by 45.0% to $56.3 million. Adjusted EBITDA grows by 28.2% to $109.8 million. Cash flow from operations is $61.0 million. Full year 2023 guidance includes net revenue of $4.23 billion to $4.28 billion, adjusted EBITDA of $420 million to $425 million, and cash flow from operations of at least $350 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.49%
Tags
earnings
News
Option Care Health to Announce Third Quarter 2023 Financial Results and Host Conference Call
Rhea-AI Summary
Option Care Health Inc. will release Q3 2023 results on October 25, 2023 before the market opens. A conference call will be held at 8:30 a.m. ET to review the results. Participants can pre-register for the call at the provided link. A replay will be available for on-demand listening.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
earnings
Stock OPCH logo
Option Care Health Inc.

Nasdaq:OPCH

OPCH Rankings

#1184 Ranked by Market Cap
#2824 Ranked by Stock Gains
N/A Ranked by Dividends

OPCH Stock Data

5.29B
172.59M
0.55%
99.78%
2.64%
Pharmacies and Drug Stores
Retail Trade
Link
US
Bannockburn

About OPCH

as of august 7, 2019, option care and bioscrip have merged to become one national team, solely dedicated to infusion care. option care health, inc. is the largest independent home and alternate site infusion services provider in the united states. with over 6,000 teammates including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. through our clinical leadership, expertise and national scale, option care health is reimagining the infusion care experience for patients, customers and employees.